The 38-year-old information technology worker from New Mexico had a prescription
in 2024 and about 178,000 deaths each year from excessive alcohol use
Homan J, Betzel B, Aarts EO, van Laarhoven KJ, Janssen IM, Berends FJ
This transition is expected to: Increase competition through biosimilar entrants Expand access in emerging markets Drive cost optimization across supply chains From a MedTech perspective, the implications are profound
Global status report on noncommunicable diseases, 2014
(Source: In August 2025 , Viking Therapeutic announced encouraging mid-stage trial results for its experimental oral/injectable weight loss drug VK2735, which achieved up to 12.2% body weight reduction over 12 weeks, through shares dropped due to higher treatment discontinuation from gastrointestinal side effects